Arcadia Biosciences (RKDA) Depreciation & Amortization (CF) (2016 - 2025)
Arcadia Biosciences' Depreciation & Amortization (CF) history spans 12 years, with the latest figure at $2000.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) rose 105.88% year-over-year to $2000.0; the TTM value through Dec 2025 reached $32000.0, down 21.95%, while the annual FY2025 figure was $32000.0, 44.83% down from the prior year.
- Depreciation & Amortization (CF) reached $2000.0 in Q4 2025 per RKDA's latest filing, roughly flat from $2000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $253000.0 in Q3 2021 to a low of -$116000.0 in Q4 2023.
- Average Depreciation & Amortization (CF) over 5 years is $75700.0, with a median of $61000.0 recorded in 2023.
- Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 218.92% in 2021, then crashed 236.47% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $192000.0 in 2021, then plummeted by 55.73% to $85000.0 in 2022, then plummeted by 236.47% to -$116000.0 in 2023, then skyrocketed by 70.69% to -$34000.0 in 2024, then soared by 105.88% to $2000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Depreciation & Amortization (CF) are $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $15000.0 (Q2 2025).